May 12, 2021

COVID Vaccine: After Pfizer and Serum Institute, Bharat Biotech applies for emergency use of Covaxin – The Financial Instances Video



Bharat Biotech on Monday utilized for emergency use authorisation for its indigenously developed COVID-19 vaccine ‘Covaxin’ to Medicine Controller Basic of India (DCGI), officers mentioned. Bharat Biotech is the third firm which has utilized for emergency use authorisation for its vaccine. It’s the second Indian firm to use for emergency use authorisation after the Serum Institute of India utilized for such use for a vaccine developed by Oxford College and AstraZeneca. Pfizer had utilized for the emergency use authorisation to DCGI on December 6.